Works by Unseld, Anna
Results: 7
Survodutide, a glucagon receptor/glucagon‐like peptide‐1 receptor dual agonist, improves blood pressure in adults with obesity: A post hoc analysis from a randomized, placebo‐controlled, dose‐finding, phase 2 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2025, v. 27, n. 2, p. 993, doi. 10.1111/dom.16052
- By:
- Publication type:
- Article
Biotransformation and mass balance of the SGLT2 inhibitor empagliflozin in healthy volunteers.
- Published in:
- Xenobiotica, 2015, v. 45, n. 6, p. 520, doi. 10.3109/00498254.2014.999141
- By:
- Publication type:
- Article
Survodutide for treatment of obesity: rationale and design of two randomized phase 3 clinical trials (SYNCHRONIZE™‐1 and ‐2).
- Published in:
- Obesity (19307381), 2025, v. 33, n. 1, p. 67, doi. 10.1002/oby.24184
- By:
- Publication type:
- Article
Pharmacokinetics and safety of olodaterol administered with the respimat soft Mist inhaler in subjects with impaired hepatic or renal function.
- Published in:
- International Journal of COPD, 2016, v. 11, p. 585, doi. 10.2147/COPD.S94234
- By:
- Publication type:
- Article
Comparative Responses in Lung Function Measurements with Tiotropium in Adolescents and Adults, and Across Asthma Severities: A Post Hoc Analysis.
- Published in:
- Pulmonary Therapy, 2020, v. 6, n. 1, p. 131, doi. 10.1007/s41030-020-00113-w
- By:
- Publication type:
- Article
Tiotropium Respimat<sup>®</sup> in asthma: a double-blind, randomised, dose-ranging study in adult patients with moderate asthma.
- Published in:
- Respiratory Research, 2014, v. 15, n. 6, p. 1, doi. 10.1186/1465-9921-15-61
- By:
- Publication type:
- Article
Tiotropium Respimat® in asthma: a double-blind, randomised, dose-ranging study in adult patients with moderate asthma.
- Published in:
- 2014
- By:
- Publication type:
- journal article